Welcome to our dedicated page for BRAIN SCIENTIFIC news (Ticker: BRSF), a resource for investors and traders seeking the latest updates and insights on BRAIN SCIENTIFIC stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect BRAIN SCIENTIFIC's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of BRAIN SCIENTIFIC's position in the market.
Piezo Motion, a company under Brain Scientific (OTCQB:BRSF), unveiled its new rotary motors designed for advanced applications in drones and satellites. These motors boast rapid response times, high torque, and micro-radian resolution, offering over one million steps per rotation, significantly outperforming traditional DC motors. The official launch will occur at the Sixth Annual Energy, Drone & Robotics Summit on June 20-22, where Piezo Motion will showcase its technology. A detailed whitepaper on these motors is now available.
Piezo Motion, a Brain Scientific company, has partnered with Hatley & Associates to enhance motion control solutions for OEM manufacturers in the eastern United States. This collaboration will leverage Piezo Motion's specialized rotary and linear motors, which boast unique features such as torque retention when powered off. The technology is aimed at sectors like biomedicine and industrial systems, helping reduce costs while improving efficiency. This deal reflects Piezo Motion's commitment to innovation in automation technology, aligning with the growing demand for precise, energy-efficient motor solutions.
Brain Scientific (OTCQB:BRSF) reported its business highlights and financial results for Q1 2022. Total revenues were approximately $159,588, significantly up from $1,475 year-over-year. The company incurred a net loss of $2,159,938 compared to $654,004 in the prior year. Key highlights include partnerships to expand product reach in Eastern Europe and the U.S., as well as the presentation of their neurology products to NATO. The company appointed new executives to enhance revenue generation efforts.
Brain Scientific (OTCQB:BRSF) is set to showcase its innovative NeuroCap™ device at the NATO Center of Excellence for Military Medicine, highlighting its potential for improving EEG accessibility for military personnel. The NeuroCap™ allows field medics to record EEG data in remote locations, greatly enhancing patient care. CEO Hassan Kotob emphasizes the device's life-saving potential in conflict zones. Brain Scientific aims to advance the future of neurodiagnostic solutions with its FDA-cleared products, which are designed to simplify testing and reduce costs.
Piezo Motion, a Brain Scientific company, has partnered with CODICO GmbH to offer advanced motion control solutions across Eastern Europe, specifically in Poland, Austria, Hungary, Czech Republic, and Slovakia. This collaboration aims to provide OEMs with innovative, cost-effective motion control motors, leveraging Piezo Motion's expertise in automation technology. The partnership is expected to address a significant demand for precision motion products in diverse sectors, including medical devices and robotics. The venture highlights Piezo Motion's commitment to enhancing functionality while ensuring affordability.
Piezo Motion, a company under Brain Scientific (OTCQB: BRSF), has partnered with Micro Technology Group (MTG) to provide motion control and automation solutions for OEM manufacturers in the northeastern U.S.
This collaboration leverages Piezo Motion’s precision motor technology, enhancing MTG’s product offerings in aerospace, defense, medical, and industrial sectors. Piezo Motion motors promise stability and reduced costs. Strong demand for these ultra-precise motors indicates growth potential in the market.
On April 21, Piezo Motion will hold a webinar featuring Dr. Mark Broderick, discussing their innovative miniature precision motors for medical devices and high-tech industries. The motors aim to enhance speed, size, and accuracy for manufacturers of blood pressure monitors and medical robots, among others. CEO Hassan Kotob highlighted the growing interest from various sectors including biomedicine and optics. Piezo Motion is committed to offering cost-effective solutions, expanding its applications across diverse industries such as automotive and nanotechnology.
Brain Scientific (OTCQB: BRSF) reported its fourth quarter and full year financial results for 2021, marking significant growth with total revenues of approximately $265,747, up from $93,664 in 2020. The company's merger with Piezo Motion and the appointment of new executives support its aggressive growth strategy in the medical technology sector. However, net losses expanded to $9,100,686 from $2,803,029 the previous year. Cash reserves improved to $785,363 from $68,943, though operating cash usage rose significantly.
Piezo Motion, a company under Brain Scientific (OTCQB:BRSF), has partnered with MEV Elektronik Service GmbH to provide advanced motion control and automation solutions for original equipment manufacturers in central and eastern Europe. This collaboration will leverage Piezo Motion's precision motor technology, enabling MEV to deliver affordable, high-precision products. With applications spanning various sectors, including medical technology and biotechnology, this partnership aims to enhance customer offerings without significant price increases, thus expanding Piezo Motion’s market reach in Europe.
Brain Scientific has appointed Felicia Maher and Todd Bertrand as Vice Presidents of Medical Products and Motion Products Sales, respectively. This strategic move aims to boost revenue growth and expand market presence for the company's innovative offerings, including the NeuroCap and NeuroEEG devices. Felicia has 17 years of experience in medical sales, while Todd brings over 20 years of technological sales expertise. Both executives are tasked with enhancing sales channels and securing a global distributor network.
FAQ
What is the market cap of BRAIN SCIENTIFIC (BRSF)?
